Alternative Investing Private equity acquires a taste for drug development Private equity firms that deemed drug development too risky for their liking in the past…Media9th January 2023
EFT Investing Equities, bonds ETFs drew in near-record amounts of cash in 2022 Investors ploughed $867 billion into ETPs (exchange-traded products) in 2022, the second biggest inflow after…Media9th January 2023
Merger Arbitrage UK battery startup Britishvolt in talks to sell majority stake The battery startup Britishvolt is in talks to sell the majority of its shares to…Media9th January 2023
Merger Arbitrage AstraZeneca boosts heart, kidney business with $1.8 bln CinCor deal AstraZeneca (AZN.L) said on Monday it had struck a deal to buy U.S.-based drug developer…Media9th January 2023
Real Assets Stocks extend solid start to year, oil prices rebound Stock markets mostly extended the solid start to the year on Thursday as China reopens…Media5th January 2023
Real Assets Crude oil ends 2022 with second straight annual gain Oil prices fluctuated wildly in 2022, rising on limited supply due to the conflict in…Media4th January 2023
Equities Gloom and boom: Fund managers’ top picks for 2023 King Dollar's reign (definitely) coming to an end, bonds bouncing and emerging markets rising again…Media3rd January 2023
Real Estate 5 ways to make affordable housing for all in 2023 Right now, it's harder than ever to buy a home. In 2022, an astronomical rise…Media1st January 2023
Real Estate The use of 3D printing in homebuilding is set to drastically expand in 2023 The use of 3D printing in homebuilding is set to drastically expand in 2023. Take…Media30th December 2022
Equities What investors watch out for in emerging markets in 2023 It has been a rough 12 months for emerging markets that have seen more governments…Media28th December 2022